Despite much controversy surrounding the clinical use of the absolute value of PSA in both the detection and monitoring of prostate cancer (Kim and Andriole, 2015), it has been shown to be an effective and inexpensive way to follow a patient’s response trajectory over time. The gene discussed is KLK3; the disease is Familial prostate cancer.